Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients
NCT04002323
·
clinicaltrials.gov ↗
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
Dolutegravir 50mg Tab
DRUG:
Lamivudine 300 mg
Sponsor
University Hospital Virgen de las Nieves